Los Angeles Capital Management LLC Neoleukin Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$1.72 - $5.23 $88,499 - $269,099	-51,453 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$4.65 - $7.75 $41,013 - $68,355	8,820 Added 20.69%	51,453 $248,000
Q3 2021 Nov 08, 2021	SELL	$6.05 - $9.66 $22,566 - $36,031	-3,730 Reduced 8.05%	42,633 $308,000
Q2 2021 Aug 05, 2021	BUY	$9.23 - $13.12 $175,028 - $248,794	18,963 Added 69.21%	46,363 $428,000
Q1 2021 May 05, 2021	BUY	$11.26 - $15.78 $88,841 - $124,504	7,890 Added 40.44%	27,400 $337,000
Q4 2020 Feb 04, 2021	BUY	$10.17 - $14.56 $198,416 - $284,065	19,510 New	19,510 $275,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.